目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
Media and reagents - Market size and forecast 2020-2025
Equipment - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape
Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Cobra Biologics Ltd.
Danaher Corp.
Lonza Group Ltd.
Merck KGaA
Molecular Devices LLC
Promega Corp.
Sartorius AG
Selexis SA
Thermo Fisher Scientific Inc.
WuXi Biologics (Cayman) Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Media and reagents - Market size and forecast 2020-2025 ($ million)
24: Media and reagents - Year-over-year growth 2020-2025 (%)
25: Equipment - Market size and forecast 2020-2025 ($ million)
26: Equipment - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Product
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Cobra Biologics Ltd. - Overview
48: Cobra Biologics Ltd. - Product and service
49: Cobra Biologics Ltd. - Key offerings
50: Cobra Biologics Ltd. - Key customers
51: Cobra Biologics Ltd. - Segment focus
52: Danaher Corp. - Overview
53: Danaher Corp. - Business segments
54: Danaher Corp. - Key offerings
55: Danaher Corp. - Key customers
56: Danaher Corp. - Segment focus
57: Lonza Group Ltd. - Overview
58: Lonza Group Ltd. - Business segments
59: Lonza Group Ltd. - Key offerings
60: Lonza Group Ltd. - Key customers
61: Lonza Group Ltd. - Segment focus
62: Merck KGaA - Overview
63: Merck KGaA - Business segments
64: Merck KGaA - Key offerings
65: Merck KGaA - Key customers
66: Merck KGaA - Segment focus
67: Molecular Devices LLC - Overview
68: Molecular Devices LLC - Product and service
69: Molecular Devices LLC - Key offerings
70: Molecular Devices LLC - Key customers
71: Molecular Devices LLC - Segment focus
72: Promega Corp. - Overview
73: Promega Corp. - Product and service
74: Promega Corp. - Key offerings
75: Promega Corp. - Key customers
76: Promega Corp. - Segment focus
77: Sartorius AG - Overview
78: Sartorius AG - Business segments
79: Sartorius AG - Key offerings
80: Sartorius AG - Key customers
81: Sartorius AG - Segment focus
82: Selexis SA - Overview
83: Selexis SA - Business segments
84: Selexis SA - Key offerings
85: Selexis SA - Key customers
86: Selexis SA - Segment focus
87: Thermo Fisher Scientific Inc. - Overview
88: Thermo Fisher Scientific Inc. - Business segments
89: Thermo Fisher Scientific Inc. - Key offerings
90: Thermo Fisher Scientific Inc. - Key customers
91: Thermo Fisher Scientific Inc. - Segment focus
92: WuXi Biologics (Cayman) Inc. - Overview
93: WuXi Biologics (Cayman) Inc. - Business segments
94: WuXi Biologics (Cayman) Inc. - Key offerings
95: WuXi Biologics (Cayman) Inc. - Key customers
96: WuXi Biologics (Cayman) Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations